TURBT removes visible bladder tumor tissue and gives pathology the staging information treatment depends on.
Transurethral resection of bladder tumor is performed through a scope to remove visible bladder tumor tissue. It is both diagnostic and therapeutic: pathology helps determine grade, stage, muscle involvement, and whether intravesical therapy, repeat resection, surveillance, or cystectomy discussion is needed.
Who this may fit
- Patients with a bladder mass seen on cystoscopy or imaging.
- Men and women with hematuria workup findings suspicious for bladder tumor.
- Patients who need staging before intravesical therapy or cystectomy decisions.
Evaluation before treatment
Preoperative planning reviews cystoscopy findings, imaging, urine studies, anticoagulants, anesthesia risk, and whether postoperative intravesical therapy is appropriate.
The pathology report drives the next step, so complete sampling and staging matter.
Recovery and follow-up
Temporary catheter, burning, urgency, blood in urine, and activity restriction may occur.
Follow-up reviews pathology and surveillance schedule because bladder tumors can recur.
Common questions
Does TURBT cure bladder cancer?
It can treat some non-muscle-invasive tumors, but follow-up and sometimes additional therapy are often needed.
Why might a second TURBT be needed?
Repeat resection may be recommended for staging accuracy or high-risk findings.
Related patient guides
Sources